TY - JOUR
AU - Vento, R.
AB - This study describes the molecular mechanism by which treatment with 3‐AB, a potent inhibitor of PARP, allows human osteosarcoma MG‐63 cells to restrict growth and enter differentiation. Our findings show that in MG‐63 cells, aberrant gene expression keeps Rb protein constitutively inactivated through hyperphosphorylation and this promotes uncontrolled proliferation of the cells. After 3‐AB‐treatment, the poly(ADP‐ribosyl)ation of nuclear proteins markedly decreases and this results in an increase in both the hypophosphorylated active form of Rb and pRb/E2F complexes. These effects are accompanied by G1 arrest, downregulation of gene products required for proliferation (cyclin D1, β‐catenin, c‐Jun, c‐Myc and Id2) and upregulation of those implicated in the osteoblastic differentiation (p21/Waf1, osteopontin, osteocalcin, type I collagen, N‐cadherins and alkaline phosphatase). Our study suggests that use of PARP inhibitors may induce a remodeling of chromatin with the reprogramming of gene expression and the activation of differentiation.
TI - Differentiative pathway activated by 3‐aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG‐63 cells
JF - Febs Letters
DO - 10.1016/j.febslet.2004.12.028
DA - 2005-01-31
UR - https://www.deepdyve.com/lp/wiley/differentiative-pathway-activated-by-3-aminobenzamide-an-inhibitor-of-LMjemO5oie
SP - 615
EP - 620
VL - 579
IS - 3
DP - DeepDyve
ER -